Dominic Boardman

Dr. Dominic Boardman is a postdoctoral research fellow in the Department of Surgery at the University of British Columbia. He currently works in Dr. Megan Levings’ lab at BC Children’s Hospital Research Institute. His research focuses on the biology of regulatory T cells (Tregs) and how these immune cells can be used as a therapy to treat inflammatory disorders, autoimmune diseases and transplant rejection.

Dominic obtained his PhD in Transplant Immunology & Mucosal Biology at King’s College London, UK. His doctoral research was supported by a PhD Studentship awarded through the Guy’s and St Thomas’ Biomedical Research Centre.

For his doctoral thesis, Dominic explored the benefits of using chimeric antigen receptor (CAR) technology to improve the therapeutic efficacy of human Tregs for treating transplant rejection. He was subsequently awarded a Canadian Institute of Health Research (CIHR) Fellowship to investigate this strategy as a means of treating inflammatory bowel disease.

As an MSFHR Research Trainee award recipient, Dominic aims to use novel gene editing techniques (CRISPR) to maximise the efficacy of CAR Tregs and promote their implementation in the clinic.

For an up-to-date list of publications by Dominic, please see his NCBI bibliography.